Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Net Income towards Common Stockholders (2016 - 2025)

Jaguar Health (JAGX) has disclosed Net Income towards Common Stockholders for 11 consecutive years, with -$7.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 2.03% to -$7.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$30.9 million, a 11.81% increase, with the full-year FY2024 number at -$38.5 million, up 6.8% from a year prior.
  • Net Income towards Common Stockholders was -$7.2 million for Q3 2025 at Jaguar Health, up from -$8.0 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$5.0 million in Q4 2024 to a low of -$18.0 million in Q1 2022.
  • A 5-year average of -$10.4 million and a median of -$9.5 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Biggest YoY gain for Net Income towards Common Stockholders was 47.03% in 2022; the steepest drop was 49.77% in 2022.
  • Jaguar Health's Net Income towards Common Stockholders stood at -$14.3 million in 2021, then soared by 47.03% to -$7.6 million in 2022, then dropped by 20.96% to -$9.2 million in 2023, then soared by 45.2% to -$5.0 million in 2024, then tumbled by 44.16% to -$7.2 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Net Income towards Common Stockholders are -$7.2 million (Q3 2025), -$8.0 million (Q2 2025), and -$10.6 million (Q1 2025).